Retinitis Pigmentosa News and Research

RSS
Retinitis pigmentosa (RP) is the name given to a group of inherited eye diseases that affect the retina (the light-sensitive part of the eye). RP causes the breakdown of photoreceptor cells (cells in the retina that detect light). Photoreceptor cells capture and process light helping us to see. As these cells breakdown and die, patients experience progressive vision loss. The most common feature of all forms of RP is a gradual breakdown of rods (retinal cells that detect dim light) and cones (retinal cells that detect light and color). Most forms of RP first cause the breakdown of rod cells. These forms of RP, sometimes called rod-cone dystrophy, usually begin with night blindness. Night blindness is somewhat like the experience normally sighted individuals encounter when entering a dark movie theatre on a bright, sunny day. However, patients with RP cannot adjust well to dark and dimly lit environments.
Leading entrepreneurs, innovators to take part in Royal Society of Medicine's 12th Medical Innovations Summit

Leading entrepreneurs, innovators to take part in Royal Society of Medicine's 12th Medical Innovations Summit

Retina Implant receives CE approval for latest Alpha AMS device

Retina Implant receives CE approval for latest Alpha AMS device

Amarantus BioScience Holdings closes $3M investment

Amarantus BioScience Holdings closes $3M investment

Study reveals another clue to workings of trachoma

Study reveals another clue to workings of trachoma

CUMC, Iowa scientists use CRISPR to repair genetic mutation responsible for retinitis pigmentosa

CUMC, Iowa scientists use CRISPR to repair genetic mutation responsible for retinitis pigmentosa

Shire announces resubmission of lifitegrast NDA to FDA for treatment of dry eye disease in adults

Shire announces resubmission of lifitegrast NDA to FDA for treatment of dry eye disease in adults

Incidence of childhood myopia has more than doubled over last 50 years among American children

Incidence of childhood myopia has more than doubled over last 50 years among American children

New gene editing technique could hinder retinal degeneration in rats with inherited blindness

New gene editing technique could hinder retinal degeneration in rats with inherited blindness

Dompé’s investigational biotech molecule receives orphan drug designation for treatment of neurotrophic keratitis

Dompé’s investigational biotech molecule receives orphan drug designation for treatment of neurotrophic keratitis

Nightstar announces $35 million Series B financing round

Nightstar announces $35 million Series B financing round

Saint Louis University ophthalmologist offers tips to manage night vision issues

Saint Louis University ophthalmologist offers tips to manage night vision issues

Gene therapy preserves vision in canine model of late-stage retinitis pigmentosa

Gene therapy preserves vision in canine model of late-stage retinitis pigmentosa

Penn researchers show that canine X-linked retinitis pigmentosa can be cured over the long term

Penn researchers show that canine X-linked retinitis pigmentosa can be cured over the long term

Lonza, Benitec partner to develop scalable manufacturing process for AAV-based viral gene therapies

Lonza, Benitec partner to develop scalable manufacturing process for AAV-based viral gene therapies

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Benitec prices initial public offering of 1,500,000 American Depositary Shares

Benitec prices initial public offering of 1,500,000 American Depositary Shares

First clinical trial to test use of retinal progenitor cells for treating retinitis pigmentosa begins

First clinical trial to test use of retinal progenitor cells for treating retinitis pigmentosa begins

Sigma 1 receptor appears to play vital role in supporting the retina

Sigma 1 receptor appears to play vital role in supporting the retina

Shire acquires Foresight Biotherapeutics for $300 million

Shire acquires Foresight Biotherapeutics for $300 million